Published in Oncotarget on January 20, 2015
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell (1999) 25.75
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med (2011) 24.32
Epigenetics in human disease and prospects for epigenetic therapy. Nature (2004) 11.46
The DNA methyltransferases of mammals. Hum Mol Genet (2000) 10.66
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer (2006) 8.57
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. Gastroenterology (2008) 3.28
Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene. Gastroenterology (2004) 2.11
Relevance of DNA methylation in the management of cancer. Lancet Oncol (2003) 1.97
Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? Ann Surg Oncol (2010) 1.82
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma. Gastroenterology (2012) 1.67
Cancer-linked DNA hypomethylation and its relationship to hypermethylation. Curr Top Microbiol Immunol (2006) 1.59
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia. Blood (2012) 1.51
Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors. Cancer Biol Ther (2010) 1.50
DNA methyltransferases as targets for cancer therapy. Drugs Today (Barc) (2007) 1.33
Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis. J Clin Invest (2012) 1.33
Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker. Drug Resist Updat (2004) 1.32
Decitabine. Recent Results Cancer Res (2010) 1.07
Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors. Epigenomics (2010) 1.05
Epigenetics and epigenetic alterations in pancreatic cancer. Int J Clin Exp Pathol (2008) 1.05
Decitabine. Curr Opin Oncol (2003) 0.95
Transcriptional dissection of pancreatic tumors engrafted in mice. Genome Med (2014) 0.92
Unlike pancreatic cancer cells pancreatic cancer associated fibroblasts display minimal gene induction after 5-aza-2'-deoxycytidine. PLoS One (2012) 0.82
Effect of inhibition of MEK pathway on 5-aza-deoxycytidine-suppressed pancreatic cancer cell proliferation. Genet Mol Res (2013) 0.77
IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer. Cancer Res (2015) 1.97
Pancreatic cancer-induced cachexia is Jak2-dependent in mice. J Cell Physiol (2014) 0.94
Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma. Oncotarget (2015) 0.89
Rapid on-site cytopathological examination (ROSE) performed by endosonagraphers and its improvement in the diagnosis of pancreatic solid lesions. Acta Cir Bras (2015) 0.80
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Gut (2016) 0.79
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity. Cancer Res (2016) 0.77
Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation. Sci Rep (2015) 0.76
P8 deficiency increases cellular ROS and induces HO-1. Arch Biochem Biophys (2014) 0.76
A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT. Oncotarget (2016) 0.75
Functional Characterization of Nupr1L, A Novel p53-Regulated Isoform of the High-Mobility Group (HMG)-Related Protumoral Protein Nupr1. J Cell Physiol (2015) 0.75
Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts. EMBO Mol Med (2017) 0.75
REG3β Plays a Key Role in IL17RA Protumoral Effect-Response. Cancer Res (2016) 0.75
Combined AURKA and H3K9 Methyltransferase Targeting Inhibits Cell Growth by Inducing Mitotic Catastrophe. Mol Cancer Res (2017) 0.75
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts. Cell Rep (2017) 0.75